A 1.62% spike in the crypto market has brought in some modest bullish waves. Certain digital assets are charted in the green, with the tokens like Bitcoin (BTC)A 1.62% spike in the crypto market has brought in some modest bullish waves. Certain digital assets are charted in the green, with the tokens like Bitcoin (BTC)

Hyperliquid (HYPE) Ignites a 22% Rally: Can Bulls Chase $30 as Volatility Creeps In?

3 min read
  • Hyperliquid rockets 22%, trading at $27.
  • HYPE’s trading volume has exploded by 98%.

A 1.62% spike in the crypto market has brought in some modest bullish waves. Certain digital assets are charted in the green, with the tokens like Bitcoin (BTC) and Ethereum (ETH) attempting to reclaim the lost momentum. Aligning with the brief uptick, Hyperliquid (HYPE) has posted a 22.22% jump over the last 24 hours. 

The opening price of the asset today was at a low of $22.03. With the sturdy bullish encounter in the HYPE market, the price climbed to a high range of $27.21, after testing and breaking pivotal resistance between $22.13 and $27.11 to confirm the uptrend. Upon the bulls staying for a longer period, the price could see more gains. 

HYPE price (Source: CMC)

At the time of writing, Hyperliquid traded at around the $27.05 mark, with its market cap staying at $8.23 billion. Besides, the daily trading volume of the asset has exploded by over 98.11%, reaching the $426.59 million zone. As per Coinglass data, the market has witnessed a 24-hour liquidation of $5.40 million worth of HYPE.

With the recent bullish trading pattern, the Hyperliquid price could move up to the resistance at around $27.20. An extended, powerful upside pressure might trigger the golden cross and send the price higher. Assuming Hyperliquid opts for a bearish reversal, the price could slip and find the nearest support below $26.90. If the potential downside correction strengthens, the death cross unfolds, and pushes it to former lows. 

Hyperliquid’s Charts Flash Bullish as Momentum Builds

The technical analysis of Hyperliquid reports that the Moving Average Convergence Divergence (MACD) line is found above the signal line, indicating bullish momentum. The recent price action is gaining strength to the upside and is considered a potential buy signal.

HYPE chart (Source: TradingView)

In addition, the Chaikin Money Flow (CMF) indicator value at 0.15 suggests positive buying pressure in the HYPE market. Money is flowing into the asset more than out, supporting the bullish sentiment and showing accumulation, if it stays above zero for the short term.

Hyperliquid’s daily Relative Strength Index (RSI) resting at 77.19 implies its ongoing overbought conditions. With the strong bullish momentum, it also raises the risk of a short-term pullback or consolidation if the buyers start taking profits. Moreover, the Bull Bear Power (BBP) reading of 5.074 signals that the bulls are firmly in control. It is pushing the HYPE price above the average, and if combined with overbought signals, it may also hint at a possible short-term cooldown.

Top Updated Crypto News

Bitmine Stakes Over 2 Million ETH, Targets $160 Million in Annual Rewards

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29